Skip to content

A comparison of dexmedetomidine and midazolam for sedation in transesophageal echocardiography.

A comparison of dexmedetomidine and midazolam for sedation in transesophageal echocardiography.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201308095381N7
Enrollment
60
Registered
2015-01-27
Start date
2013-06-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient cerebral ischaemic attack. Transient cerebral ischaemic attack, unspecified

Interventions

Intervention 1: The first group will received 2 mgmidazolam before the procedure and if needed additional midazolam will be added. Intervention 2: The second group will received an infusion of dexme
Treatment - Drugs
The first group will received 2 mgmidazolam before the procedure and if needed additional midazolam will be added.
The second group will received an infusion of dexmedetomidine1 mcg/kg/minand reduced to 0.2 mcg/kg/min after probe insertion.

Sponsors

Vice-chancellor of Research Babol University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: exclusion criteria: previous TEE and upper digestive system endoscopic examinations; emergency examinations; pregnancy; mechanical ventilation; patients with psychiatric and emotional disorder;history of addiction;history of allergic reaction. Inclusion criteria:patients scheduled forTEE; patients with a history of transient cerebral ischaemic attack?ages of 18-60years

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sedation level. Timepoint: Observation during echography. Method of measurement: Ramsy sedation score.;Patient satisfaction. Timepoint: after echocardiography. Method of measurement: Visual analoge scale.

Secondary

MeasureTime frame
Recovery time. Timepoint: end of TEE. Method of measurement: minute.;Nausea and vomiting. Timepoint: End of TEE. Method of measurement: Direct inspection and history.;Hypoxia. Timepoint: during and after TEE. Method of measurement: pulse oximetry.;Blood pressure. Timepoint: during and after TEE. Method of measurement: Noninvasive cuff measurrment.;Heart rate. Timepoint: during and after TEE. Method of measurement: pulse counting.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Nadia Banihashem

Babol University of Medical Sciences

nbanihashem@yahoo.com+98 112238296

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026